Table 1.

Depletion of NK cells using anti-asialo GM1 antibody in BALB/c.B6Cmv1rmice

Tissue*nNo. leukocytes
(×10−6)
% NK1.1+
NK cells
% TCRβ+
cells
% NK1.1+
TCRβ+cells
Spleen 105 ± 51-153 3.0 ± 0.4 25 ± 2 0.4 ± 0.1 
Spleen + Ab 90 ± 7 < 0.2 26 ± 3 0.5 ± 0.2 
Liver 2.4 ± 0.4 19.7 ± 1.4 43 ± 4 7.7 ± 1.3 
Liver + Ab 2.8 ± 0.1 0.3 ± 0.1 44 ± 4 7.5 ± 3.4 
Tissue*nNo. leukocytes
(×10−6)
% NK1.1+
NK cells
% TCRβ+
cells
% NK1.1+
TCRβ+cells
Spleen 105 ± 51-153 3.0 ± 0.4 25 ± 2 0.4 ± 0.1 
Spleen + Ab 90 ± 7 < 0.2 26 ± 3 0.5 ± 0.2 
Liver 2.4 ± 0.4 19.7 ± 1.4 43 ± 4 7.7 ± 1.3 
Liver + Ab 2.8 ± 0.1 0.3 ± 0.1 44 ± 4 7.5 ± 3.4 

Cell suspensions were prepared as described and labeled with mAb specific for αβTCR and NK1.1.

*

Mice were untreated or treated with 100 μg anti-asialo GM1 one day before tissue harvest.

n, number of mice tested.

Total number of leukocytes isolated from spleen or liver.21 

F1-153

Results represent mean ± SE.

Close Modal

or Create an Account

Close Modal
Close Modal